Comment on “Major adverse cardiac and cerebrovascular events (MACCEs) in patients with acute ST-segment elevation myocardial infarction (STEMI) treated with pharmaco-invasive strategy of half-dose recombinant human prourokinase (PHDP): Two-year outcomes”
Bo Shang
Affiliations
Bo Shang
Corresponding author.; Gansu Provincial Maternity and Child-care Hospital (Gansu Provincial Central Hospital), Lanzhou City, People's Republic of China
